Article

Low Sensitivity of Rapid Diagnostic Test for Influenza

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clinical Infectious Diseases (Impact Factor: 9.42). 06/2009; 48(9):e89-92. DOI: 10.1086/597828
Source: PubMed

ABSTRACT The QuickVue Influenza A+B Test (Quidel) was used to test nasal swab specimens obtained from persons with influenza-like illness
in 3 different populations. Compared with reverse-transcriptase polymerase chain reaction, the test sensitivity was low for
all populations (median, 27%; range, 19%–32%), whereas the specificity was high (median, 97%; range, 96%–99.6%).

Download full-text

Full-text

Available from: Stephen S. Morse, Aug 29, 2015
0 Followers
 · 
201 Views
  • Source
    • "Commercially available, widely used rapid influenza diagnostic tests do not distinguish among influenza A virus subtypes and are less sensitive than viral culture or RT-PCR [20]. However, viral culture or RT-PCR has limitations, as they require isolation of replicating virus. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Different respiratory viruses induce virus-specific gene expression in the host. Recent evidence, including those presented here, suggests that genetically related isolates of influenza virus induce strain-specific host gene regulation in several animal models. Here, we identified systemic strain-specific gene expression signatures in ferrets infected with pandemic influenza A/California/07/2009, A/Mexico/4482/2009 or seasonal influenza A/Brisbane/59/2007. Using uncorrelated shrunken centroid classification, we were able to accurately identify the infecting influenza strain with a combined gene expression profile of 10 selected genes, independent of the severity of disease. Another gene signature, consisting of 7 genes, could classify samples based on lung pathology. Furthermore, we identified a gene expression profile consisting of 31 probes that could classify samples based on both strain and severity of disease. Thus, we show that expression-based analysis of non-infected tissue enables distinction between genetically related influenza viruses as well as lung pathology. These results open for development of alternative tools for influenza diagnostics.
    PLoS ONE 07/2012; 7(7):e40743. DOI:10.1371/journal.pone.0040743 · 3.23 Impact Factor
  • Source
    • "j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / d i a g m i c r o b i o Loeffelholz, 2010; Uyeki et al., 2009). Serologic assays for 2009 H1N1 also suffered from low sensitivity and could only be used to diagnose 2009 H1N1 retrospectively (Veguilla et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Real-time polymerase chain reaction (PCR) can be considered the gold standard for detection of influenza viruses due to its high sensitivity and specificity. Roche has developed the RealTime ready Influenza A/H1N1 Detection Set, consisting of a generic influenza virus A PCR targeting the M2 gene (M2 PCR) and a specific PCR targeting the hemagglutinin (HA) of A/H1N1-pdm09 (HA PCR, 2009 H1N1), with the intention to make a reliable, rapid, and simple test to detect and quantify 2009 H1N1 in clinical samples. We evaluated this kit against the US Centers for Disease Control and Prevention (USCDC)/World Health Organization real-time PCR for influenza virus using 419 nose and throat swabs from 210 patients collected in 3 large hospitals in Ho Chi Minh City, Vietnam. In the per-patient analysis, when compared to CDC PCR, the sensitivity and specificity of the M2 PCR were 85.8% and 97.6%, respectively; the sensitivity and specificity of HA PCR were 88.2% and 100%, respectively. In the per-sample analysis, the sensitivity and specificity in nose swabs were higher than those in throat swabs for both M2 and HA PCRs. The viral loads as determined with the M2 and HA PCRs correlated well with the Ct values of the CDC PCR. Compared with the CDC PCR, the kit has a reasonable sensitivity and very good specificity for the detection and quantification of influenza A virus and A/H1N1-pdm09. However, given the current status of 2009 H1N1, a kit that can detect all circulating seasonal influenza viruses would be preferable.
    Diagnostic microbiology and infectious disease 07/2012; 74(2):131-6. DOI:10.1016/j.diagmicrobio.2012.06.003 · 2.57 Impact Factor
  • Source
    • "After providing informed consent, each subject was given a rapid influenza test (QuickVue Influenza A+B test, Quidel). The rapid test was used to provide an initial estimate of influenza case numbers; however, because the sensitivity of the test was reported to be low [23], subjects were allowed to continue participating in the study regardless of the outcome. Two nasopharyngeal mucus swabs were collected for analysis by qPCR and viral plaque assay (VPA), the subject's oral temperature was taken, and the subject was asked to answer a brief health questionnaire. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Influenza is thought to be communicated from person to person by multiple pathways. However, the relative importance of different routes of influenza transmission is unclear. To better understand the potential for the airborne spread of influenza, we measured the amount and size of aerosol particles containing influenza virus that were produced by coughing. Subjects were recruited from patients presenting at a student health clinic with influenza-like symptoms. Nasopharyngeal swabs were collected from the volunteers and they were asked to cough three times into a spirometer. After each cough, the cough-generated aerosol was collected using a NIOSH two-stage bioaerosol cyclone sampler or an SKC BioSampler. The amount of influenza viral RNA contained in the samplers was analyzed using quantitative real-time reverse-transcription PCR (qPCR) targeting the matrix gene M1. For half of the subjects, viral plaque assays were performed on the nasopharyngeal swabs and cough aerosol samples to determine if viable virus was present. Fifty-eight subjects were tested, of whom 47 were positive for influenza virus by qPCR. Influenza viral RNA was detected in coughs from 38 of these subjects (81%). Thirty-five percent of the influenza RNA was contained in particles>4 µm in aerodynamic diameter, while 23% was in particles 1 to 4 µm and 42% in particles<1 µm. Viable influenza virus was detected in the cough aerosols from 2 of 21 subjects with influenza. These results show that coughing by influenza patients emits aerosol particles containing influenza virus and that much of the viral RNA is contained within particles in the respirable size range. The results support the idea that the airborne route may be a pathway for influenza transmission, especially in the immediate vicinity of an influenza patient. Further research is needed on the viability of airborne influenza viruses and the risk of transmission.
    PLoS ONE 11/2010; 5(11):e15100. DOI:10.1371/journal.pone.0015100 · 3.23 Impact Factor
Show more